Details of issuance or disposal
Monthly exercise status of the Series 6 Stock Acquisition Rights, Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Provisions) issued through a third-party allotment
Shares delivered during the month under the Series 7 Stock Acquisition Rights: 291,100 (291,100 new shares and 0 transferred treasury shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Against 2,911,799 listed shares as of the payment date for the issuance, 291,100 shares were delivered during the month, with an exercise ratio subject to the exercise restriction of 10.0%.
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Series 6 Stock Acquisition Rights, Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 7 Stock Acquisition Rights (with Exercise Price Adjustment Provisions) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month under the Series 7 Stock Acquisition Rights: 291,100 (291,100 new shares and 0 transferred treasury shares) |
| Intended allottee | GP Listed Company Investment Limited Liability Partnership (allottee of the Series 6 Stock Acquisition Rights, Series 1 unsecured convertible bonds with stock acquisition rights and Series 7 Stock Acquisition Rights) |
| Dilution Rate | Against 2,911,799 listed shares as of the payment date for the issuance, 291,100 shares were delivered during the month, with an exercise ratio subject to the exercise restriction of 10.0%. |
| Total number of issued shares | 4,342,998 shares as of the end of the preceding month → Not disclosed |
| Exercise price | The exercise price of the Seventh Series Stock Acquisition Rights was stated as ranging from ¥199 to ¥300 during the month. The lower limit under the adjustment provision was Not disclosed. |
| Number of Stock Acquisition Rights | During the month, 2,911 Seventh Series Stock Acquisition Rights were exercised; 7,139 remained unexercised at the end of the preceding month and 4,228 remained unexercised at month-end. The total number issued was Not disclosed. For the Sixth Series Stock Acquisition Rights, 8,288 remained unexercised both at the end of the preceding month and at month-end; the total number issued was Not disclosed. |
| Procedures under the Corporate Code of Conduct | Disclosure of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange Rules for Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | Issued on 14 April 2025: Sixth Series Stock Acquisition Rights and First Series Unsecured Convertible Bonds with Stock Acquisition Rights (detailed amount Not disclosed), Issued on 15 June 2026: Seventh Series Stock Acquisition Rights with an exercise price adjustment provision (detailed amount Not disclosed) |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The monthly exercise status is being disclosed because, under the rules of the Tokyo Stock Exchange, the Series 6 Stock Acquisition Rights and Series 1 unsecured convertible bonds with stock acquisition rights are deemed to be “MSCBs, etc.” as a result of the issuance of the Series 7 Stock Acquisition Rights.